Canna Law Blog

MARCH 25, 2025

Can businesses cultivate cannabis for pharmaceutical research? Employers should: Establish fair and transparent testing policies. Can employers enforce a zero-tolerance cannabis policy? Businesses should ensure written policies are consistent with relevant state and federal employment law.

Research and Development 92

Research and Development Medicine Compliance Compliance 92

Cannabis Law Report

SEPTEMBER 10, 2021

Brazilian pharmaceutical company Prati-Donaduzzi, whose 20 year patent to produce CBD oil was recently revoked, offers an alternative to imported products—even though it is manufactured with imported raw material.

Policy 103

Policy Oil Concentrates Pharmaceutical 103

NORML

AUGUST 26, 2019

There are currently five “pharmaceutical processor” permit holders in Virginia, and they’re about to open for business. Now, in 2015 — like in many other states throughout the country — we saw some fresh faces in the marijuana policy conversation. They managed to hold on to that.

Marijuana 231

Marijuana Legalization Programs Oil 231

CannaTech

SEPTEMBER 23, 2019

The pleas of parents fighting to treat their sick children are impossible to ignore, as evidenced by the impact of Billy Caldwell and Alfie Dingley’s parents in shifting the regulatory framework for UK cannabis policy. UK cannabis policy is not serving the interests of patients.

Patients 79

Patients Policy Clinical Trials Research and Development 79

NORML

MARCH 14, 2019

Our veterans deserve the option to legally access a botanical product that is objectively safer than the litany of pharmaceutical drugs it could replace. A recently released poll conducted by The American Legion showed that nearly 1 in 4 veterans self-reported using marijuana to alleviate a medical or physical condition.

Access 232

Access Chronic Pain Treatment Conditions 232

Project CBD

JANUARY 31, 2023

26, the FDA issued a CBD policy statement that reaffirmed its longstanding unwillingness or inability to regulate nonpharmaceutical CBD products. ” As per usual, the FDA reflexively privileges pharmaceutical CBD, which is so safe it’s not even considered a controlled substance.

CBD 130

CBD Clinical Trials Pharmaceutical Food 130

Project CBD

MARCH 8, 2019

Immediately in response, the FDA announced that CBD is considered a “drug” and is thus subject to pharmaceutical regulations. As of February 2019, the Veterinary Medical Board in California still has no official policy on hemp products. Medical Cannabis in California.

Pets 218

Pets Legalization Hemp Extraction 218

NORML

JUNE 13, 2019

Millions of Americans are legally replacing pharmaceuticals with cannabis and the question of affordability has become critical. Are you paying too much for medical marijuana? All of the state programs are independent and in various stages of maturity. Prices, even for closely similar products, have a wide range.

Marijuana 276

Marijuana Dispensary Patients Retail 276

Cannabis Law Report

NOVEMBER 22, 2021

Not only that, but lawyers are being hired in-house at psychedelic research and pharmaceutical companies and others are applying their legal skills to regulatory issues. Top 200 Global Psychedelic Lawyers and Policy & Regulatory Experts Guide. The Very Best Psychedelics Legal & Policy Thinkers.

Policy 52

Policy Legalization Pharmaceutical Media 52

The Cannigma

FEBRUARY 8, 2021

But when it comes to law and policy, what are the definitive terms we should be using when talking about cannabis? Published in Drug Science, Policy and Law , the study is the first of its kind to examine the different nomenclature systems used for cannabis in the worlds of law and academia. Not always, according to a new study.

Cannabinoids 145

Cannabinoids Sativa Policy Hemp 145

Veriheal

JANUARY 21, 2021

Although many of these athletes did not consume cannabis prior to games, fights, and other competitions but rather in their own free times, it did not matter as cannabis has been listed in many of the leagues’ anti-doping and drug policies since their inception. A Statement Regarding the Changes. Athletes That Have Come Forward.

Policy 59

Policy THC Therapy Chronic Pain 59

Cannabis Law Report

JULY 23, 2019

(TSXV: LG and OTC-QB: LGGCF) (“ LGC ”) is pleased to announce that it has paid the 2 nd Tranche, as contractually agreed, in acquiring an equity interest in the Italian pharmaceutical company, Freia Farmaceutici Srl (“Freia”). This EU pharmaceutical entity is an optimal addition to LGC. Tel: (416) 644-2020 or (514) 939-3989.

Pharmaceutical 45

Pharmaceutical Seed-To-Sale Compliance Compliance 45

Project CBD

JULY 28, 2023

You need access to sophisticated analytical methods to discern product purity from the isomeric byproducts formed, which is why production from hemp-derived cannabinoid products needs to be done under the appropriate FDA regulations for API [active pharmaceutical ingredient] synthesis and manufacturing.

THC 217

THC Cannabinoids Hemp Research and Development 217

Cannabis Law Report

JUNE 17, 2021

Patients are looking to their medical providers for information on cannabis safety, potential for interactions with pharmaceuticals, and therapeutic applications. cannabis policy are needed, particularly at the federal level. As cannabis use expands in the U.S., Without clinical guidance or a coherent regulatory framework, the U.S.

Policy 61

Policy Research and Development Medicine Safety 61

Cannabis Law Report

OCTOBER 26, 2019

The US subsidiary of GW Pharmaceuticals, behind the only FDA-approved cannabis extract-based medicine, is lobbying in all 50 states. GW is the world’s oldest and largest pharmaceutical company solely focused on producing medicines derived from cannabis plants, which it grows in Britain. By Nikitha Sattiraju.

Pharmaceutical 45

Pharmaceutical Research and Development Banking Therapy 45

Canna Law Blog

FEBRUARY 21, 2020

Although the UK recently severed its ties with the European Union, the FSA has opted to align its policy with that of the European Food Safety Authority (“ EFSA ”). Following the March 31, 2021 deadline, only products for which a valid application has been submitted will be allowed to remain on the market.

Food 121

Food CBD Legalization Hemp 121

Cannabis Law Report

NOVEMBER 23, 2021

Department of Veterans Affairs (VA) says that while current federal marijuana laws have prevented the department’s physicians from recommending medical cannabis to military veterans, officials are “looking at” the possibility of an internal policy change and have discussed it with the White House. And it was very profound,” McDonough said.

Policy 52

Policy Marijuana Pharmaceutical Treatment 52

Cannabis Law Report

JUNE 1, 2022

Pharmadrug GmbH has been active worldwide for almost 40 years as a manufacturer and wholesaler of medicinal products and active pharmaceutical ingredients. Our team in Europe is excited to join forces with new colleagues from Pharmadrug GmbH, with their valuable expertise in the German pharmaceutical market.”

Pharmaceutical 52

Pharmaceutical Medicine Extraction Cannabinoids 52

Canna Law Blog

FEBRUARY 19, 2020

The second track for psilocybin is the pharmaceutical model. On the pharmaceutical side, the FDA’s willingness to grant breakthrough therapy status to psychedelic drugs, as mentioned above, has put psilocybin approvals in an expeditious place. At some point, federal policy finally evolves and change becomes inevitable.

Decriminalization 133

Decriminalization Research and Development Therapy Pharmaceutical 133

NORML

JANUARY 11, 2019

The measure would allow Virginia’s licensed practitioners to recommend and pharmaceutical processors to dispense full therapeutic-strength medical cannabis oil. Legislation is pending, Senate Bill 1557, to expand the state’s low-THC medical cannabis oil program. NY resident? New Mexico.

Legislation 213

Legislation Decriminalization Hemp Patients 213

Cannabis Law Report

JULY 1, 2021

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is engaged in a three-year initiative to examine the ethical, legal, and social implications of psychedelics research, commerce, and therapeutics. Here’s the press release. The Project on Psychedelics Law and Regulation (POPLAR).

Law 59

Law Policy Research and Development Clinical Trials 59

Cannabis Law Report

JUNE 5, 2021

The Harare government has also approved the establishment of the Green Industry Fund, to promote local beneficiation, skills transfer and development of the local pharmaceutical industry. 100% foreign ownership a ‘significant departure from previous policy’.

Medicine 105

Medicine Pharmaceutical Agriculture Policy 105

NORML

FEBRUARY 8, 2019

Senator Ron Wyden introduced legislation in the Senate — The Marijuana Revenue and Regulation Act — to permit states to establish their own marijuana regulatory policies free from federal interference. A subcommittee of the U.S. A Georgia bill to reduce marijuana possession penalties was defeated in a senate committee this week.

Legislation 187

Legislation Decriminalization Patients Access 187

MJ Business Attorneys

JUNE 29, 2018

So for now, we wait in anticipation for the DEA to commence proceedings to determine how to amend the scheduling of CBD under the CSA in a way that will allow for Epidiolex to be prescribed by health care providers and dispensed by pharmaceutical companies appropriately and legally.

DEA 113

DEA CBD Pharmaceutical Research and Development 113

The Cannigma

MARCH 25, 2021

Executive Director of the Criminal Justice Policy Foundation told The Cannigma during a Zoom call this week. “A Sterling mentioned fears that officials may have about cannabis making its way out into the general population of the prison, though he added that’s a concern with any pharmaceutical provided by prison health services.

Marijuana 145

Marijuana Access Law Pharmaceutical 145

Cannabis Law Report

AUGUST 27, 2021

The policy for deregulation was announced on the 23rd when representatives of growers in Tochigi, Mie, Gifu Prefecture and Hokkaido visited Mr. Mitsuaki Kamada, Director of the Pharmaceutical and Living Hygiene Bureau of the Ministry of Health, Labor and Welfare. There are also regulations that are clearly overkill.

Pharmaceutical 98

Pharmaceutical Cultivation Data Policy 98

Cannabis Law Report

JUNE 28, 2021

His blend of medical, governmental, and healthcare policy experience makes him well positioned to support Kanabo’s mission to establish and lead a regulated medicinal cannabis market in the UK and Europe. Avihu Tamir, CEO, Kanabo Group, said , “We are delighted to welcome Dr Dan Poulter, MP as a Non-Executive Director to our board.

Research and Development 105

Research and Development Chronic Pain Medicine Policy 105

NORML

FEBRUARY 23, 2020

2227) is bipartisan legislation that removes marijuana from the Controlled Substances Act, thus decriminalizing the substance at the federal level and enabling states to set their own policies. The Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act (HR 3884 / S.

Legislation 250

Legislation Patients Decriminalization Access 250

The Cannigma

NOVEMBER 2, 2021

Overall, 65% of the respondents said that they use cannabis in lieu of prescription pharmaceuticals. The survey was compiled by Amanda Reiman , PhD MSW, the California policy manager for the Drug Policy Alliance. In addition, they were also significantly more likely to report more use days per week.

Cannabis 134

Cannabis Policy Pharmaceutical Patients 134

The Blunt Truth

JANUARY 20, 2023

Speaking of CBD, Google makes changes to its advertising policies. CBD ADVERTISING If you’ve wondered why you’ve never seen CBD advertising when you’re searching Google (even if you blog about cannabis news every week…), the answer is that the products are currently on Google’s Unapproved Pharmaceuticals and Supplements list.

Pharmaceutical 84

Pharmaceutical CBD Hemp Collective 84

NORML

FEBRUARY 1, 2019

At the state level, activists in Florida and Missouri gathered in their state capitals along side state and local NORML chapters to lobby state lawmakers in favor of sensible marijuana policy reform. 182 is scheduled for a hearing in the Health Policy Committee on 2/4/19 at 1:30 pm, 412 Knott Building. John Fetterman, Lt. Update : S.

Legislation 177

Legislation Decriminalization Access Patients 177

NORML

FEBRUARY 29, 2020

2227) is bipartisan legislation that removes marijuana from the Controlled Substances Act, thus decriminalizing the substance at the federal level and enabling states to set their own policies. The Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act (HR 3884 / S. Update : SB 1015 was approved by the House on 2/27/20.

Legislation 152

Legislation Decriminalization Patients Edibles 152

Cannabis Law Report

MAY 29, 2021

Canadian-owned Bophelo Bioscience and Wellness is the founding developer in the Mafeteng Special Economic Zone, created to attract investors in agriculture and pharmaceutical industries. To encourage businesses to set up in the zone, financial policies are introduced. Lesotho’s PM launches SEZ from cannabis facility.

Agriculture 97

Agriculture Collective Policy Pharmaceutical 97

Cannabis Law Report

JUNE 2, 2021

Pharmaceutical Grade CBD Oil. While Idaho does not permit the medical use of marijuana, Idaho does allow the use of pharmaceutical grade products that are approved by the Food and Drug Administration (FDA) pursuant to a prescription by a licensed healthcare provider. Idaho Office of Drug Policy: Cannabidiol (CBD): [link].

Law 103

Law Marijuana Oil Pharmaceutical 103

Cannabis Law Report

SEPTEMBER 1, 2021

Ensure that scientific data supporting submissions are following domestic and international regulations and all relevant guidelines and policies. Knowledge and experience working within a pharmaceutical manufacturing, packaging, and warehousing cGMP Quality Management System. Proficiency in English; additional languages are an asset.

Research and Development 105

Research and Development Supply Chain Compliance Compliance 105

MedicalJane

MAY 14, 2020

It continues to enforce restrictive policies and regulations on research into the health benefits or harms of cannabis products that are available to consumers across the nation.

Sleep 95

Sleep Edibles DEA Policy 95

The Cannigma

JUNE 1, 2021

Marijuana is not legal in France, and the country is seen as having some of the strictest cannabis policies in western Europe. Patients can take part if they have a medical condition which has not responded to pharmaceutical drugs. Some 170 hospitals will participate in the two-year experiment.

Law 119

Law Epilepsy Programs Patients 119